- Current report filing (8-K)
06 4월 2010 - 4:17AM
Edgar (US Regulatory)
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): April 5, 2010
TIENS
BIOTECH GROUP (USA), INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32477
|
|
75-2926439
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
|
|
Identification
Number)
|
No. 6,
Yuanquan Road, Wuqing
New-T
ech
Industrial Park, Tianjin,
China
301700
(Address
of principal executive offices)
Registrant's
telephone number, including area code:
(86)
22
-
8213-7658
Not
applicable
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
materials pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02 Results of Operations and Financial
Condition.
On April
5, 2010, Tiens Biotech Group (USA), Inc. (the “Company”) issued a press release
reporting the Company’s financial results for 2009. The full text of
the press release is set forth in Exhibit 99.1 attached hereto.
Item
9.01 Financial Statements and Exhibits.
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press
release, dated April 5,
2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TIENS
BIOTECH GROUP (USA), INC.
|
|
|
|
Date: April
5, 2010
|
By:
|
/s/ Manbo He
|
|
|
Name:
|
Manbo
He
|
|
|
Title:
|
Chief
Financial Officer
|
Exhibits
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press
release, dated April 5,
2010.
|
Tiens Biotech GR Usa (AMEX:TBV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Tiens Biotech GR Usa (AMEX:TBV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Tiens Biotech Grp. (Usa) Common Stock (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More News Articles